Arteris director’s trust sells 20,000 shares
Arteris, Inc. director Antonio J. Viana reported an open‑market sale of common stock through the Viana Family Trust.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Arteris, Inc. director Antonio J. Viana reported an open‑market sale of common stock through the Viana Family Trust. On April 17, 2026, the trust sold 20,000 shares at a weighted average price of $22.1084 per share under a pre‑arranged Rule 10b5-1 trading plan adopted on June 10, 2025. After this sale, the trust held 144,620 shares of Arteris common stock, while Viana also directly held 20,840 shares, indicating he retains a substantial equity position.
Insights
Pre-planned trust sale of 20,000 Arteris shares looks routine.
The filing shows the Viana Family Trust sold 20,000 shares of Arteris common stock at a weighted average price of $22.1084 on April 17, 2026. This is an open‑market transaction attributed to the trust, with Viana as the reporting person.
A key detail is that the sale occurred under a pre‑arranged Rule 10b5-1 trading plan adopted on June 10, 2025, which typically indicates scheduled, rather than opportunistic, selling. After the sale, the trust still held 144,620 shares and Viana also directly held 20,840 shares, so he maintains meaningful exposure.
The price disclosure is given as a weighted average, with actual trade prices ranging from $22.00 to $22.24. This pattern and the remaining holdings suggest a routine liquidity event rather than a change in overall stance, based solely on the data provided here.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 20,000 | $22.1084 | $442K |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 10, 2025.
- F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.24 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average sale price financial
open-market sale financial
indirect ownership financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Arteris (AIP) disclose for Antonio J. Viana?
Was the Arteris (AIP) insider sale made under a Rule 10b5-1 plan?
What does the weighted average sale price mean in the Arteris (AIP) filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.